The recent NJBiz article on Research on Antibiotic Resistance published in December 2018, features Dr. Keith Bostian, CEO of ILSE. Dr. Bostian discusses the research that is happening on the field at ILSE and Kean University. The full article can be viewed here
The Institute for Life Science Entrepreneurship (ILSE) has been awarded a $100,000 planning grant in partnership with Union Township to expand its outreach to life science entrepreneurs and its university programs. A Union Township proposal to expand ILSE Life Science Incubator received one of nine New Jersey Economic Development Authority…
Over the past decade, the human microbiome as an avenue for new drug discovery and development has gained significant attention from academics, industry professionals, funding agencies and investors. However, much of the data to date has only provided correlative evidence of clinical applications, leaving many technical challenges and unknowns. To…
The New Jersery Academic Drug Discovery Consortium is hosting its 2nd annual meeting at Rutgers University this year. The conference is taking place on Thursday, November 15 at the Ernest Mario School of Pharmacy. When Thursday, November 15, 2018 from 8:00 AM to 4:00 PM EST Add to Calendar Where…
ILSE is hosting the 2018 EPO session on Computer Implemented Inventions at its facilities in Union, NJ For Registration: Click Here
Institute for Life Science Entrepreneurship (ILSE) on July 18, 2018 released its white paper on innovation spaces. Entitled "Recent Advances in Laboratory and Innovation Space in New Jersey", the paper includes profiles of major biopharma incubators and innovation spaces in New Jersey and perspectives from leaders of successful industrial and…
ILSE and Microgenomx will at ASM Microbe June 7-11, 2018 at Atlanta. To contact us during the meeting please email
ILSE has shared and independent Lab and Office Space available at its Campus Location in Union, NJ 07083
ILSE has formed a new microbiology and genomics company, Microgenomx, Inc., to develop cutting edge new technology and to provide services to antibiotic, microbiome and other microbiology-related companies. We are running an introductory offer for mutational analysis studies, integrating microbiology, whole genome sequencing and bioinformatics analysis, at very attractive pricing,…
Prokaryotics Announces Licensing Agreement with Merck for Novel Investigational Antibiotic Candidates Union, NJ – January 25, 2018 -- Prokaryotics, Inc., a privately-held biopharmaceutical company engaged in the discovery and development of novel anti-infective drugs, announced today that it has entered into a licensing agreement with Merck, known as MSD…